Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.
The antiviral effect of MS8209, an amphotericin B derivative, was studied in CD4+ cells transfected with a lacZ gene inducible upon human immunodeficiency virus type 1 (HIV-1) infection. MS8209 was shown to block virus entry after receptor binding and probably before virus-cell membrane fusion, but...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188612/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7983757/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.1.570-574.1995 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|